Cryoport Investor Relations Material

Cryoport Inc is a global provider of temperature-controlled supply chain solutions, primarily serving the life sciences industry. The company specializes in supporting the logistics of temperature-sensitive materials, including those vital for cell and gene therapies, biopharmaceuticals, in vitro fertilization (IVF), surrogacy, and animal health sectors. Its services are crucial in maintaining the integrity of biological samples and products through the use of advanced cryogenic logistics solutions. Cryoport manages these shipments through its Cryoportal, a cloud-based logistics management platform that ensures the secure and efficient transport of life sciences commodities worldwide. The platform offers comprehensive management of shipment processes, including order entry, document preparation, customs documentation, courier management, real-time tracking, and regulatory compliance. The company is headquartered in Nashville, TN, and its shares are listed on the Nasdaq.